Global Statistics Representing Assisted Reproductive Technology Market Scenario
Increase in marital age, rising consumption of alcohol and tobacco leading to infertility and increasing obese population are major factors contributing significantly for the growth. As per Centers for Disease Control and Prevention (CDC), around 10 percent of women (6.1 million) in the United States have difficulty in getting pregnant. Moreover, incidences of PCOS, endometriosis and tubal factors also causes infertility. As per U.S. Department of Health and Human Services, Polycystic ovary syndrome (PCOS) affects 1 in 10 women at childbearing age. Women with PCOS have a hormonal imbalance and metabolism problems that may cause infertility.
New developments in assisted reproductive technology to provide effective solutions to patient is a key strategy of market players. For instance, in July 2017, Irvine Scientific, introduced continuous Single Culture -NX, which is a next generation single-step culture medium for embryos. In addition, in 2018, Monash IVF started using smart TV app to consult fertility patients in China. This step is a collaboration with AC International Medical Tourism (Melbourne). It enables the Chinese patients to have face to face consultation with the clinicians in Australia.
Global assisted reproductive technology market accounted for over USD 24.5 billion in 2017 and is expected to grow at a CAGR of 11.5% during the forecast period, 2019–2026.
Global assisted reproductive technology market is segmented by type, procedure and end user.
Bytype, the market is segmented intoin-vitro fertilization, artificial insemination, intracervical insemination and surrogacy. In-vitro fertilization segment is expected to grow at the fastest CAGR.The growth can be attributed to introduction of new technology. In-vitro fertilization is sub segmented into Intracytoplasmic Sperm Injection (ICSI) and IVF without ICSI.
Byprocedure, the assisted reproductive technology market is segmented into frozen non-donor, frozen donor, fresh non-donor and fresh donor. Fresh non-donor segment is projected to hold the largest share as availability of different cycles.
Based on end user, the market is segmented into fertility clinics and hospitals. Fertility clinics segment is playing a chief role in shaping business growth on account of expanding healthcare infrastructure in emerging countries and increase in infertility incidences.
Geographically, the global assisted reproductive technology market is segmented into four regions: North America, Europe, Asia Pacific, and Latin America and the Middle East & Africa (LAMEA).
Europe is likely to dominate the assisted reproductive technology market due to increasing cases of infertility, rising awareness among people for fertility treatment, technological advancements and government initiatives. Birth rates have been dropping consistently in the region. As per a policy audit on fertility in Europe, there is a high prevalence of infertility in the region and around 25 million EU citizens are affected by it.
North America is likely to emerge as the second largest assisted reproductive technology market globally. This can be attributed to awareness towards various fertility options among people and up gradation in in-vitro fertilization procedure. For instance, in August 2015 Ovascience’s treatment AUGMENT reported to have rejuvenated women’s aging egg cells and provided support to eggs with poor quality.
Asia Pacific assisted reproductive technology market is expected to witness significant growth on account of family planning programs and low cost associated with the treatment. According to the Indian Society of Assisted Reproduction, currently 10 to 14 percent of the Indian population is affected by infertility. The rate is higher in urban areas where 1 out of 6 couples is affected. Furthermore, 27.5 million couples actively trying to conceive in India.
LAMEAis expected to witness stagnent growth in the assessment period. Africa is one of the most fertile country in the world. According to the World Population Review 2018, Africa with Niger topped the list with 7.153 children per woman.
Some of the key players in the global assisted reproductive technology market are Bloom IVF Centre, OvaScience, California Cryobank, Irvine Scientific, Parallabs, Hamilton Throne Ltd, Ferring Pharmaceuticals, Origio, Anecova, Merck KGaA and Cooper Surgical, Inc.
Assisted Reproductive Technology Market Segmentation
By End User
Why buy this report?